Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 14
Partnerships 15
Melinta Therapeutics Enters into Agreement with Menarini 15
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 16
Menarini Asia-Pacific Enters into Agreement with Merck 17
Menarini Forms Joint Venture with BiosYnth 18
Moberg Extends Distribution Agreement with Menarini for Emtrix 19
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 20
Moberg Pharma Extends Distribution Agreement With Menarini 21
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 22
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 23
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 24
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 25
Licensing Agreements 26
Menarini Enters into Licensing Agreement with Daiichi Sankyo 26
Berlin-Chemie Enters into Licensing Agreement with Selvita 27
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 28
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 29
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 30
Vivus Enters Into Licensing Agreement With Menarini For Spedra 31
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 33
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 34
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 35
FAES Farma Enters into License Agreement with Menarini For Bilastina 36
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 37
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 39
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 40
Acquisition 41
Menarini Group Plans To Acquire Indian Pharma Company 41
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Competitors 42
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Employees 43
A. Menarini Industrie Farmaceutiche Riunite Srl – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 47
Recent Developments 48
Strategy And Business Planning 48
Mar 13, 2017: Menarini Arrives In Columbia And Peru Two New Offices For A Stronger Connection Between Two Continents 48
Jan 18, 2017: Menarini In Turkey: +25% Growth In 2016 And New Headquarters In Istanbul 49
Corporate Communications 50
Jun 29, 2017: Menarini Increases Number of Members of the Board – for the First Time External Members In Majority 50
Product News 51
Apr 12, 2017: Menarini Brings Sirmione Thermal Water Into Italian Homes 51
03/17/2017: Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Key Facts, 2017 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 14
Melinta Therapeutics Enters into Agreement with Menarini 15
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 16
Menarini Asia-Pacific Enters into Agreement with Merck 17
Menarini Forms Joint Venture with BiosYnth 18
Moberg Extends Distribution Agreement with Menarini for Emtrix 19
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 20
Moberg Pharma Extends Distribution Agreement With Menarini 21
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 22
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 23
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 24
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 25
Menarini Enters into Licensing Agreement with Daiichi Sankyo 26
Berlin-Chemie Enters into Licensing Agreement with Selvita 27
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 28
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 29
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 30
Vivus Enters Into Licensing Agreement With Menarini For Spedra 31
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 33
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 34
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 35
FAES Farma Enters into License Agreement with Menarini For Bilastina 36
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 37
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 39
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 40
Menarini Group Plans To Acquire Indian Pharma Company 41
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Competitors 42
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Employees 43
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries 44
A. Menarini Industrie Farmaceutiche Riunite Srl, Joint Venture 47
List of Figures
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10